Wiley Analytics Science Publication
Charles River’s Ronald Dorenbos, Executive Director Business Development, Logica, recently spoke with Wiley Analytical Science about the rise of artificial intelligence (AI) assisted drug discovery. The increasing complexity of advanced treatments and investment in drugs that do not make it successfully to market makes R&D ever more expensive. The cost of bringing a new drug to market range from $1.3 to $2.8 billion USD.
Logica, a platform launched by Charles River and Valo Health, utilizes AI-powered computation in conjunction with traditional techniques to support drug discovery.